home / stock / flhlf / flhlf news


FLHLF News and Press, Filament Health From 03/28/24

Stock Information

Company Name: Filament Health
Stock Symbol: FLHLF
Market: OTC
Website: filament.health

Menu

FLHLF FLHLF Quote FLHLF Short FLHLF News FLHLF Articles FLHLF Message Board
Get FLHLF Alerts

News, Short Squeeze, Breakout and More Instantly...

FLHLF - FILAMENT HEALTH ANNOUNCES APPOINTMENT OF MICHAEL MESSINGER TO ITS BOARD OF DIRECTORS

FILAMENT HEALTH ANNOUNCES APPOINTMENT OF MICHAEL MESSINGER TO ITS BOARD OF DIRECTORS Canada NewsWire VANCOUVER, BC , March 28, 2024 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage na...

FLHLF - FILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL INVESTIGATION

FILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL INVESTIGATION Canada NewsWire Research institutions in the United States , Canada , Israel , and Belgium , including Johns Hopkins University , will study PEX010, Fil...

FLHLF - Filament Health announces FDA opening of IND application for substance abuse disorder

--News Direct-- Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to share the groundbreaking news that the U.S. Food and Drug Administration (FDA) has given its approval for the Investigational New Drug application for PEX010, Filament Health's botanical psilocybin dr...

FLHLF - FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO ISRAEL

FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO ISRAEL Canada NewsWire Hadassah University Hospital will study PEX010, Filament's botanical psilocybin drug candidate, for the treatment of post-traumatic stress disorder and obsessive-compulsive disorder ...

FLHLF - FILAMENT HEALTH ANNOUNCES FDA OPENING OF INVESTIGATIONAL NEW DRUG APPLICATION FOR SUBSTANCE USE DISORDERS

FILAMENT HEALTH ANNOUNCES FDA OPENING OF INVESTIGATIONAL NEW DRUG APPLICATION FOR SUBSTANCE USE DISORDERS Canada NewsWire The active IND allows initiation of US research with Filament's botanical psilocybin drug candidate for the potential treatment of substance use disorders ...

FLHLF - FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO AUSTRALIA

FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO AUSTRALIA Canada NewsWire Reset Mind Sciences Ltd. has received a shipment of PEX010, Filament's botanical psilocybin drug candidate VANCOUVER, BC , Jan. 17, 2024 /CNW/ - Filament Healt...

FLHLF - FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS

FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS Canada NewsWire VANCOUVER, BC , Jan. 2, 2024 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development comp...

FLHLF - Filament Health terminates proposed business combination with Jupiter Acquisition

2023-12-20 03:50:21 ET More on Filament Health Filament Health raises $14.4M via issuance of senior secured convertible notes Filament Health signs term sheet for a $14.4M convertible note Historical earnings data for Filament Health Financial information for...

FLHLF - FILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION

FILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION Canada NewsWire VANCOUVER, BC , Dec. 19, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Compan...

FLHLF - FILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE

FILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE Canada NewsWire VANCOUVER, BC , Dec. 18, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or t...

Previous 10 Next 10